These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12882925)

  • 21. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls.
    Wabitsch M; Blum WF; Muche R; Heinze E; Haug C; Mayer H; Teller W
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1073-80. PubMed ID: 8968852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice.
    Crossey PA; Pillai CC; Miell JP
    J Clin Invest; 2002 Aug; 110(3):411-8. PubMed ID: 12163461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation of the circadian clock gene Per2 alters vascular endothelial function.
    Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z
    Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age.
    van der Kaay D; Deal C; de Kort S; Willemsen R; Leunissen R; Ester W; Paquette J; van Doorn J; Hokken-Koelega A
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1386-92. PubMed ID: 19158202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance.
    Vicent D; Ilany J; Kondo T; Naruse K; Fisher SJ; Kisanuki YY; Bursell S; Yanagisawa M; King GL; Kahn CR
    J Clin Invest; 2003 May; 111(9):1373-80. PubMed ID: 12727929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein-1 and -2 gene expression in experimental uremia.
    Tönshoff B; Powell DR; Zhao D; Durham SK; Coleman ME; Domené HM; Blum WF; Baxter RC; Moore LC; Kaskel FJ
    Endocrinology; 1997 Mar; 138(3):938-46. PubMed ID: 9048593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats.
    Novosyadlyy R; Dargel R; Scharf JG
    Growth Horm IGF Res; 2005 Oct; 15(5):313-23. PubMed ID: 16098781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice.
    Tivesten A; Bollano E; Andersson I; Fitzgerald S; Caidahl K; Sjögren K; Skøtt O; Liu JL; Mobini R; Isaksson OG; Jansson JO; Ohlsson C; Bergström G; Isgaard J
    Endocrinology; 2002 Nov; 143(11):4235-42. PubMed ID: 12399417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.
    Lang CH; Vary TC; Frost RA
    Endocrinology; 2003 Sep; 144(9):3922-33. PubMed ID: 12933666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM).
    Gibson JM; Westwood M; Young RJ; White A
    J Clin Endocrinol Metab; 1996 Feb; 81(2):860-3. PubMed ID: 8636318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice.
    Sakai K; D'Ercole AJ; Murphy LJ; Clemmons DR
    Diabetes; 2001 Jan; 50(1):32-8. PubMed ID: 11147791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of endothelium-specific insulin resistance on endothelial function in vivo.
    Duncan ER; Crossey PA; Walker S; Anilkumar N; Poston L; Douglas G; Ezzat VA; Wheatcroft SB; Shah AM; Kearney MT
    Diabetes; 2008 Dec; 57(12):3307-14. PubMed ID: 18835939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of insulin-like growth factor binding protein-1 during the 24-hour metabolic clock and in response to hypoinsulinemia induced by fasting and Sandostatin in normal women.
    Holden JP; Butzow TL; Laughlin GA; Ho M; Morales AJ; Yen SC
    J Soc Gynecol Investig; 1995; 2(1):38-44. PubMed ID: 9420847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium.
    Messmer-Blust AF; Philbrick MJ; Guo S; Wu J; He P; Guo S; Li J
    Circ Res; 2012 Sep; 111(8):991-1001. PubMed ID: 22843786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls.
    Rutanen EM; Stenman S; Blum W; Kärkkäinen T; Lehtovirta P; Stenman UH
    J Clin Endocrinol Metab; 1993 Jul; 77(1):199-204. PubMed ID: 7686914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
    Duncan ER; Walker SJ; Ezzat VA; Wheatcroft SB; Li JM; Shah AM; Kearney MT
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1311-9. PubMed ID: 17711985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects of human IGFBP-3 and its mutant IGFBP-3 devoid of IGF binding ability.
    Nguyen KH; Yao XH; Erickson AG; Mishra S; Nyomba BL
    Endocrinology; 2015 Feb; 156(2):462-74. PubMed ID: 25490144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF-binding protein-2 protects against the development of obesity and insulin resistance.
    Wheatcroft SB; Kearney MT; Shah AM; Ezzat VA; Miell JR; Modo M; Williams SC; Cawthorn WP; Medina-Gomez G; Vidal-Puig A; Sethi JK; Crossey PA
    Diabetes; 2007 Feb; 56(2):285-94. PubMed ID: 17259371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.